Facebook
Twitter
Telegram
Report an ErrorAvanos Medical Balance Sheet 2011-2024 | AVNS
Annual Balance Sheet Avanos Medical
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
111 M | 26.2 M | 84 M | 120 M | -137 M | 361 M | 465 M | 449 M | 487 M | -32.2 M | 28 M | - |
Long Term Debt |
226 M | 130 M | 180 M | 248 M | 248 M | 541 M | 579 M | 578 M | 632 M | - | - | - |
Long Term Debt Current |
12.8 M | 14.7 M | 15.5 M | 14.7 M | - | 39.8 M | - | - | 3.9 M | - | - | - |
Total Non Current Liabilities |
- | - | - | 322 M | 272 M | 591 M | 645 M | 630 M | 680 M | 94.5 M | 119 M | - |
Total Current Liabilities |
186 M | 139 M | 166 M | 212 M | 264 M | 390 M | 324 M | 315 M | 356 M | - | - | - |
Total Liabilities |
496 M | 333 M | 416 M | 534 M | 536 M | 980 M | 969 M | 945 M | 1.04 B | 405 M | 478 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-253 M | -304 M | -316 M | -288 M | -242 M | -300 M | -379 M | -419 M | 7.3 M | - | - | - |
Total Assets |
1.79 B | 1.6 B | 1.67 B | 1.8 B | 1.83 B | 2.2 B | 2.07 B | 2 B | 2.53 B | 2.48 B | 2.53 B | - |
Cash and Cash Equivalents |
128 M | 118 M | 112 M | 205 M | 384 M | 220 M | 114 M | 130 M | 149 M | 44.1 M | 47.9 M | - |
Book Value |
1.29 B | 1.27 B | 1.26 B | 1.27 B | 1.3 B | 1.22 B | 1.1 B | 1.06 B | 1.49 B | 2.08 B | 2.06 B | - |
Total Shareholders Equity |
1.29 B | 1.27 B | 1.26 B | 1.27 B | 1.3 B | 1.22 B | 1.1 B | 1.06 B | 1.49 B | 2.08 B | 2.06 B | - |
All numbers in USD currency
Quarterly Balance Sheet Avanos Medical
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
167 M | 159 M | 258 M | 203 M | 205 M | 226 M | 248 M | 249 M | 254 M | 130 M | 145 M | 165 M | 175 M | 180 M | 180 M | 180 M | 180 M | 248 M | 248 M | 248 M | 248 M | 248 M | 248 M | 248 M | 248 M | 541 M | 541 M | 541 M | 541 M | 579 M | 579 M | 579 M | 579 M | 578 M | 578 M | 578 M | 578 M | 623 M | 632 M | 632 M | 632 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 93.4 M | 93.6 M | 52.1 M | 51.6 M | 52.6 M | 51.6 M | 51.6 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 94.5 M | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
433 M | 456 M | 503 M | 432 M | 436 M | 496 M | 512 M | 501 M | 510 M | 333 M | 336 M | 387 M | 396 M | 416 M | 416 M | 416 M | 416 M | 534 M | 534 M | 534 M | 534 M | 536 M | 536 M | 536 M | 536 M | 980 M | 980 M | 980 M | 980 M | 969 M | 969 M | 969 M | 969 M | 945 M | 945 M | 945 M | 945 M | 1.03 B | 1.04 B | 1.04 B | 1.04 B | 405 M | 405 M | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-316 M | -315 M | -325 M | -322 M | -254 M | -253 M | -270 M | -293 M | -304 M | -304 M | -310 M | -285 M | -323 M | -316 M | -316 M | -316 M | -316 M | -288 M | -288 M | -288 M | -288 M | -242 M | -242 M | -242 M | -242 M | -300 M | -300 M | -300 M | -300 M | -379 M | -379 M | -379 M | -379 M | -419 M | -419 M | -419 M | -419 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.66 B | 1.69 B | 1.72 B | 1.67 B | 1.73 B | 1.79 B | 1.78 B | 1.75 B | 1.77 B | 1.6 B | 1.6 B | 1.68 B | 1.65 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.8 B | 1.8 B | 1.8 B | 1.8 B | 1.83 B | 1.83 B | 1.83 B | 1.83 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.07 B | 2.07 B | 2.07 B | 2.07 B | 2 B | 2 B | 2 B | 2 B | 2.52 B | 2.53 B | 2.53 B | 2.53 B | 2.48 B | 2.48 B | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
75.8 M | 87.7 M | 107 M | 81.8 M | 95.7 M | 128 M | 117 M | 106 M | 104 M | 118 M | 97.8 M | 99.9 M | 100 M | 112 M | 112 M | 112 M | 112 M | 205 M | 205 M | 205 M | 205 M | 384 M | 384 M | 384 M | 384 M | 220 M | 220 M | 220 M | 220 M | 114 M | 114 M | 114 M | 114 M | 130 M | 130 M | 130 M | 130 M | 149 M | 149 M | 149 M | 149 M | 44.1 M | 44.1 M | - | - | 47.9 M | - | - | - | 20.1 M | - | - | - |
Book Value |
1.23 B | 1.24 B | 1.22 B | 1.23 B | 1.3 B | 1.29 B | 1.26 B | 1.25 B | 1.26 B | 1.27 B | 1.26 B | 1.3 B | 1.25 B | 1.26 B | 1.26 B | 1.26 B | 1.26 B | 1.27 B | 1.27 B | 1.27 B | 1.27 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.22 B | 1.22 B | 1.22 B | 1.22 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 1.49 B | 1.49 B | 1.49 B | 1.49 B | 2.08 B | 2.08 B | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
1.23 B | 1.24 B | 1.22 B | 1.23 B | 1.3 B | 1.29 B | 1.26 B | 1.26 B | 1.26 B | 1.27 B | 1.27 B | 1.3 B | 1.26 B | 1.26 B | 1.26 B | 1.26 B | 1.26 B | 1.27 B | 1.27 B | 1.27 B | 1.27 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.22 B | 1.22 B | 1.22 B | 1.22 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 1.49 B | 1.49 B | 1.49 B | 1.49 B | 2.08 B | 2.08 B | - | - | 2.06 B | - | - | - | 2 B | - | - | - |
All numbers in USD currency